Core Viewpoint - Grupo Aeroportuario del Pacífico (GAP) has successfully paid off the bond certificate "GAP 23L" amounting to Ps.1,120.0 million, utilizing proceeds from a new credit facility with Scotiabank Inverlat [1][2]. Company Overview - Grupo Aeroportuario del Pacífico operates 12 airports in Mexico's Pacific region, including major cities like Guadalajara and Tijuana, as well as tourist destinations such as Puerto Vallarta and Los Cabos [3]. - The company was listed on the New York Stock Exchange in February 2006 and on the Mexican Stock Exchange in the same year [3]. - GAP acquired a majority stake in MBJ Airports Limited in April 2015 and entered into a concession agreement for the Norman Manley International Airport in Jamaica in October 2018 [3].

Core Viewpoint - Grupo Aeroportuario del Pacífico has successfully refinanced a bank loan of USD 95.5 million with BBVA México, extending its financing terms and maintaining liquidity [1][2]. Group 1: Loan Details - The new loan has a six-month term with an option to extend for an additional six months [2]. - Interest on the loan is payable monthly at a variable rate equivalent to SOFR plus 40 basis points, with a structuring fee of 10 basis points [2]. - If the extension option is exercised, an additional fee of 10 basis points will apply, and the principal will be paid at maturity [2]. Group 2: Company Overview - Grupo Aeroportuario del Pacífico operates 12 airports in Mexico's Pacific region, including major cities like Guadalajara and Tijuana, as well as tourist destinations such as Puerto Vallarta and Los Cabos [3]. - The company was listed on the New York Stock Exchange in February 2006 and on the Mexican Stock Exchange in the same year [3]. - GAP acquired a majority stake in MBJ Airports Limited in April 2015 and entered into a concession agreement for the Norman Manley International Airport in Jamaica in October 2018 [3].

Core Viewpoint - A securities fraud lawsuit has been filed against Richtech Robotics Inc. and certain executives due to allegations of misrepresentation regarding their relationship with Microsoft, leading to significant stock price decline and investor losses [1][2][3]. Group 1: Allegations and Impact - Richtech Robotics' shares fell over 20% on January 29, 2026, after a report claimed the company misrepresented its relationship with Microsoft, describing a non-commercial engagement as a "close collaboration" [2]. - The report indicated that Microsoft characterized the engagement as a standard customer program without commercial elements, contradicting Richtech's public statements [2]. - The lawsuit alleges that Richtech's claims about its business and prospects were materially false and misleading, resulting in investor damages when the true details became public [3]. Group 2: Investor Eligibility and Actions - Investors who purchased Richtech Robotics common stock between January 27, 2026, and January 29, 2026, and experienced a decline in share value may be eligible to participate in the lawsuit [4]. - The deadline for seeking appointment as lead plaintiff is April 3, 2026, and investors are encouraged to contact Block & Leviton for more information [5]. Group 3: Whistleblower Information - Individuals with non-public information about Richtech Robotics are encouraged to assist in the investigation or file a report with the SEC under the whistleblower program, potentially receiving rewards of up to 30% of any successful recovery [6]. Group 4: Legal Representation - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [7].

Core Viewpoint - Corcept Therapeutics experienced a significant decline in share price, dropping 50% after receiving a complete response letter from the FDA regarding its treatment relacorilant for hypercortisolism, leading to a loss of over $3.6 billion in market capitalization [1][3]. Company Overview - Corcept Therapeutics has previously promoted relacorilant's efficacy and commercial potential, claiming that clinical trial patients showed meaningful improvements in hypercortisolism symptoms [3]. - The company expressed confidence in achieving annual revenues of $3 billion to $5 billion from its hypercortisolism business within three to five years [3]. FDA Response - The FDA's complete response letter indicated that additional evidence of relacorilant's effectiveness was required for a favorable benefit-risk assessment [3]. - A reported finding indicated that loss of blood pressure control was 83% less likely in the relacorilant group compared to placebo [3]. Market Reaction - Following the FDA's announcement, Corcept's share price fell over $35, resulting in a 50% decrease in value on December 31, 2025 [1][3].

Core Viewpoint - A securities fraud lawsuit has been filed against Quanex Building Products Corporation and certain executives following disappointing financial results and allegations of misleading investors regarding operational issues at its Tyman facility [1][2][3]. Financial Performance - On September 4, 2025, Quanex reported a diluted EPS of ($6.04), a significant decline from $0.77 in the same quarter the previous year, attributed to ongoing operational issues at the Tyman hardware facility in Mexico [2]. - The company's stock price fell over 23% in two trading days following the earnings announcement [2]. Allegations - The lawsuit claims that Quanex misled investors by not disclosing the poor condition of the Tyman facility, the associated risks, and the negative impact on expected cost savings and integration benefits [3]. Eligibility for Lawsuit - Investors who purchased Quanex common stock between December 12, 2024, and September 5, 2025, and experienced a decline in share value may be eligible to participate in the lawsuit [4]. Next Steps for Investors - The deadline to seek appointment as lead plaintiff is November 18, 2025, and a class has not yet been certified [5]. Whistleblower Information - Individuals with non-public information about Quanex are encouraged to assist in the investigation or file a report with the SEC under the whistleblower program, potentially receiving rewards of up to 30% of any successful recovery [6]. Firm Background - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [7].

Company Overview - Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (GAP) operates 12 airports in Mexico's Pacific region, including major cities like Guadalajara and Tijuana, and tourist destinations such as Puerto Vallarta and Los Cabos [3] - GAP's shares are listed on the New York Stock Exchange under the ticker symbol "PAC" and on the Mexican Stock Exchange under "GAP" [3] - The company acquired a majority stake in MBJ Airports Limited, which operates Sangster International Airport in Jamaica, and entered into a concession agreement for the Norman Manley International Airport in Kingston, Jamaica [3] Dividend Announcement - GAP will pay the second and final installment of the approved dividend on August 14, 2025, amounting to Ps. 8.42 per outstanding share [1][2] - This payment completes a total dividend of Ps. 16.84 per share, as approved at the Annual General Ordinary Shareholders' Meeting held on April 24, 2025 [2]

Group 1 - The company Grupo Aeroportuario del Pacífico (GAP) made a payment of Ps. 2,500.0 million for the maturity of the debt securities "GAP 21" on May 2, 2025, which corresponds to 25 million long-term debt securities with a face value of Ps. 100.0 each [1] - GAP operates 12 airports in Mexico's Pacific region, including major cities like Guadalajara and Tijuana, and tourist destinations such as Puerto Vallarta and Los Cabos [2] - The company was listed on the New York Stock Exchange in February 2006 and acquired a majority stake in MBJ Airports Limited in April 2015, which operates Sangster International Airport in Jamaica [2] Group 2 - GAP entered into a concession agreement for the operation of Norman Manley International Airport in Kingston, Jamaica, in October 2018 and took control of the operation in October 2019 [2] - The company has implemented a whistleblower program in accordance with the Sarbanes-Oxley Act, allowing anonymous reporting of suspected criminal conduct or violations [4]